Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Statements of Operations

v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenues $ 515 $ 10,959 $ 299
Cost of revenues 1,625 1,991 400
Gross profit (loss) (1,110) 8,968 (101)
Operating expenses:      
Research and development 10,515 10,484 10,255
General, administrative and marketing 5,626 5,996 6,741
Total operating loss (17,251) (7,512) (17,097)
Financial income, net 642 493 172
Net loss $ (16,609) $ (7,019) $ (16,925)
Basic net loss per ordinary share (in Dollars per share) $ (1.45) $ (0.62) $ (1.53)
Diluted net loss per ordinary share (in Dollars per share) (in Dollars per share) $ (1.45) $ (0.62) $ (1.53)
Weighted average number of ordinary shares used in computation of basic and net loss per share (in Shares) 11,454,180 11,389,168 11,033,310
Weighted average number of ordinary shares used in computation of diluted net loss per share (in Shares) (in Shares) 11,454,180 11,389,168 11,033,310